ibuprofen soft capsules market REPORT OVERVIEW
The global Ibuprofen Soft Capsules Market Size was valued at USD 396.79 million in 2024 and is projected to reach USD 413.45 Million in 2025, growing to USD 574.61 Million by 2033, with exhibiting CAGR of 4.2% during the forecast period.
Ibuprofen is a non-steroidal and anti-inflammatory medicine. It prevents creation of prostaglandins that give ache and soreness. It is extensively used attributable to its properties such as anti-inflammation, analgesic, and antipyretic. The soft capsules are formulated for efficient and easy digestion delivery methods for ibuprofen. It finds extensive applications in pain management and inflammation related problems. It offers patients a convenient and effective alternative to traditional tablet formulations.
Growing requirement for pain relief medication, this market is witnessing momentous growth. Rising chronic disease and aging populace are offering avenues to market players to grow their market presence in the coming years.
COVID-19 Impact
The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.
COVID-19 pandemic significantly inclined the market. In the pandemic, concerns appeared about its possible deepening of COVID-19 symptoms. Although subsequent research didn’t decisively support these worries. The initial anxiety led to a temporary decline in ibuprofen use. However, as more information appeared, assurance in its safety increased. The pandemic also highlighted the magnitude of pain and fever relief, with ibuprofen enduring a crucial over-the-counter alternative for managing symptoms related with COVID-19 and other diseases.
LATEST TRENDS
Digital Marketing and e-Commerce Platforms Propelling Market Advancement
Trend going on for this market is the increasing use of digital platforms for marketing and the e-commerce channels are propelling the market advancement. These platforms are influential for ibuprofen market growth and extending support in reaching a wider audience and enhancing consumer engagement.
Market SEGMENTATION
By Type
Based on type the market can be categorized into 200 mg & 400 mg
- 200 mg: 200 mg ibuprofen is taken by adults and children aged 12 years and above that are used for pain relief such as muscular pain, rheumatic, headache, and others.
- 400 mg: 400mg ibuprofen is used for mild to moderate pain relief from the non-serious arthritic conditions, dental pain, backache, headache, and others.
By Application
Based on application the market can be categorized into Hospital, Clinic, & Other
- Hospital: Hospital utilizes ibuprofen capsules for inpatients and outpatients for treatment of various pains and disorders.
- Clinic: Clinic also has these capsules for prescribing for a variety of pain and inflammation conditions.
- Other: There are other healthcare centers where these capsules are available such as pharmacies, and others.
DRIVING FACTORS
Increasing Chronic Disease and Aging Population Propel Market Growth
Primary growing factor for the Ibuprofen Soft Capsules Market Growth is the increasing chronic disease and growing aging population. Chronic disease such as arthritis and musculoskeletal disorders is increasing at a fast rate which is propelling the market growth. Due to the effective management of pain and inflammation related issues attract consumers that increase demand for the capsule and support the expansion of the market. Escalating elderly population globally is another attribute which is fueling the market growth. Elderly people often experience joint and muscle pain, to get relief from these pains, increasing customer demand and supporting the market growth.
Rising Awareness of Self-Medications and Pharmaceutical Industry Expand Market
Another trait helping in expansion of the market is raising awareness of self-medications and the pharmaceutical industry. Leaning towards self-medications by consumers choosing over-the-counter remedies to address common pains has increased the market. Pharmaceutical industry is expanding due to the improvement in drug delivery systems encouraging the market growth. The focus on improving formulation of Ibuprofen is boosting the market growth.
RESTRAINING FACTOR
Rising Side Effects and Increasing Alternative Solutions Hindered Market Growth
Limiting factors for the market growth are the rising side effects of these capsules and the increasing alternative solutions in the market. These factors are hindering the market growth significantly. Increasing consciousness about side-effects on prolonged use obstruct demand for these capsules and consequently hampering market growth. Market is having strong rivalry from other pain management therapies. Medication and physical therapy is discouraging customers from using these capsules and subsequently hindering market progress.
REGIONAL INSIGHTS
The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.
Request a Free sample to learn more about this report.
North America Dominates the Market due to Entrenched Pharmaceutical Industry
The North America region is dominating the Ibuprofen Soft Capsules Market Share due to a well-established pharmaceutical industry in this region. The region exhibited a robust market performance and showcased a comprehensive regional analysis. Increased expenditure on healthcare and strong focus on wellness has supported market expansion and rising awareness of pain management in the creasing demand for these capsules. The availability of its accessibility through various channels has contributed to market growth in this region.
KEY INDUSTRY PLAYERS
Key Players Transforming the Ibuprofen Soft Capsules Landscape through Diversification of Product and Strategy Partnership
Many prominent industry players are operating in this market focused on improvement of formulations and diversification of products to be in the competition. However, there are many companies in the market that use some techniques such as merger, acquisitions, partnership and using new advanced technologies for producing and developing new products and stay ahead in the market.
List of Market Players Profiled
- Glaxosmithkline (U.K.)
- Nurofen (U.K.)
- Galpharm (U.K.)
- Bell's Healthcare (U.K.)
- Walgreens (U.S.)
- SINOPharm (China)
- HAPharm Group (U.K.)
INDUSTRIAL DEVELOPMENT
April 2024: NPPA released a notice for increasing the cost of prescription drugs such as ibuprofen and others. This notice states that the MRP of the scheduled formulations will rise by 0.00551 % starting with the commencement of the fiscal year 2024-25.
REPORT COVERAGE
This report is based on historical analysis and forecast calculation that aims to help readers get a comprehensive understanding of the global ibuprofen soft capsules market from multiple angles, which also provides sufficient support to readers’ strategy and decision-making. Also, this study comprises a comprehensive analysis of SWOT and provides insights for future developments within the market. It examines varied factors that contribute to the growth of the market by discovering the dynamic categories and potential areas of innovation whose applications may influence its trajectory in the upcoming years. This analysis encompasses both recent trends and historical turning points into consideration, providing a holistic understanding of the market’s competitors and identifying capable areas for growth.
This research report examines the segmentation of the market by using both quantitative and qualitative methods to provide a thorough analysis that also evaluates the influence of strategic and financial perspectives on the market. Additionally, the report's regional assessments consider the dominant supply and demand forces that impact market growth. The competitive landscape is detailed meticulously, including shares of significant market competitors. The report incorporates unconventional research techniques, methodologies and key strategies tailored for the anticipated frame of time. Overall, it offers valuable and comprehensive insights into the market dynamics professionally and understandably.
- 26426821
- North America
- 113
Clients
Top Trending
Contact Information
Frequently Asked Questions
-
What value is the Ibuprofen Soft Capsules Market expected to touch by 2033?
The ibuprofen soft capsules market is expected to reach USD 574.61 million by 2033.
-
What CAGR is the Ibuprofen Soft Capsules Market expected to exhibit by 2033?
The ibuprofen soft capsules market is expected to exhibit a CAGR of 4.20% by 2033.
-
Which are the driving factors of the Ibuprofen Soft Capsules Market?
Increasing Chronic Disease and Aging Population Propel Market Growth and Rising Awareness of Self-Medications and Pharmaceutical Industry Expand Market are some of the driving factors of the market.
-
What are the key Ibuprofen Soft Capsules Market segments?
The key market segmentation that you should be aware of, which include, based on type, the ibuprofen soft capsules market is classified as 200 mg & 400 mg. Based on application, the ibuprofen soft capsules market is classified as Hospital, Clinic, & Other.